Literature DB >> 1513918

Predictors of placebo response: a retrospective analysis.

C S Wilcox1, J B Cohn, R D Linden, J F Heiser, P B Lucas, D L Morgan, D DeFrancisco.   

Abstract

This retrospective evaluation involved 197 patients from independent clinical investigations of four antidepressant medications. Six variables were analyzed for their discriminative utility in predicting placebo response rates: gender; marital status; age; education; duration of illness; and severity of depressive symptomatology, as measured by Hamilton Rating Scale for Depression (HAM-D or HDRS) scores. Men were slightly more responsive to placebo than were women (29.8%, n = 94 vs. 24.3%, n = 103). Married patients demonstrated the highest probability of a positive placebo response (38.15%, n = 76), as compared with widowed/separated/divorced (21.9%, n = 73) or single (16.7%, n = 48) patients. A trend toward an increased probability of placebo response was detected for patients aged 60 and above (35.7%, n = 14). Educational level achieved and duration of illness were not predictive. Severity of illness proved most noteworthy, with the placebo response rate higher in the more mild patients (40.8%, n = 27 vs. 23.4%, n = 77).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513918

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  5 in total

1.  A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.

Authors:  Melissa P DelBello; Thomas J Hochadel; Kimberly Blanchard Portland; Albert J Azzaro; Alain Katic; Arif Khan; Graham Emslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-06-23       Impact factor: 2.576

2.  Influence of the behaviour pattern on the nocebo response of healthy volunteers.

Authors:  M D Drici; F Raybaud; C De Lunardo; P Iacono; P Gustovic
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

3.  A comparison of placebo responders and nonresponders in subgroups of depressive disorder.

Authors:  R J Bialik; A V Ravindran; D Bakish; Y D Lapierre
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

Review 4.  Mechanisms of the placebo effect in pain and psychiatric disorders.

Authors:  R D Holmes; A K Tiwari; J L Kennedy
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550

5.  Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients.

Authors:  Giovanni Camardese; Beniamino Leone; Riccardo Serrani; Coco Walstra; Marco Di Nicola; Giacomo Della Marca; Pietro Bria; Luigi Janiri
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-09       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.